Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

investor.lilly.com/news-releases/news-release-details/lilly-acquire-verve-therapeutics-advance-one-time-treatments

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by targeting genes strongly linked to cardiovascular disease
Lilly's established…

This story appeared on investor.lilly.com, 2025-06-17 12:45:18.656000.
The Entire Business World on a Single Page. Free to Use →